Hope in sight with Apellis’ pegcetacoplan OAKS/DERBY results for GA
pharmaphorum
NOVEMBER 16, 2022
And yet, the OAKS study, as well as the DERBY study, has illuminated possible hope on the horizon. All of these statistical comparisons are nominal, but the nominal p-values were highly significant at 0.003 or less.”. It will be interesting to see what the outcome of that application is. Bleak prospects, indeed.
97 
Let's personalize your content